Sign in

CIK 0000948320

  • Accelerated filer

LifeMD, Inc.

Sign in to watch
Ticker
LFMD
Exchange
Nasdaq
Industry
Services-Offices & Clinics of Doctors of Medicine
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
760238453
Phone
+1 866-351-5907
Business address
236 FIFTH AVENUE, SUITE 400, NEW YORK, NY, 10001
Former names
CONVERSION LABS, INC., Immudyne, Inc.

Securities

  • LFMD Common Stock Nasdaq
  • LFMDP 8.875% Series A Cumulative Perpetual Preferred Stock Nasdaq
  1. 4 Open-market buy Chief Compliance Officer bought 5,000 shares at an average $20.08 ($100,400)
  2. 4 Open-market buy Chief Operating Officer bought 5,000 shares at $20.50 ($102,500)
  3. 3 Insider Initial Statement of Ownership
  4. 3 Insider Initial Statement of Ownership
  5. 3 Insider Initial Statement of Ownership
  6. 4 Gift Chief Executive Officer gave 20,000 shares (gift)
  7. 3 Insider Initial Statement of Ownership
  8. 3 Insider Initial Statement of Ownership
  9. 4 Grant or award Chief Technology Officer acquired 1,000,000 shares (grant or award)
  10. 4 Grant or award Chief Executive Officer acquired 1,000,000 shares (grant or award)
  11. 4 Derivatives Options or other derivatives
  12. 3 Insider Initial Statement of Ownership
  13. 4 Option exercise Chief Acquisition Officer acquired 105,288 shares (option exercise)
  14. 3 Insider Initial Statement of Ownership
  15. 3 Insider Initial Statement of Ownership
  16. 4 Grant or award Director acquired 800,000 shares (grant or award)
  17. 4 Open-market sale Chief Operating Officer sold 401,000 shares at $1.00 ($401,000)
  18. 4 Open-market buy Director bought 45,000 shares at an average $1.29 ($58,093)
  19. 4 Open-market buy Director bought 65,000 shares at an average $1.42 ($92,009)
  20. 4 Open-market buy Director bought 1,300 shares at an average $0.81 ($1,047)

Page 9 of 12 · 230 filings